Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:14 PM
Ignite Modification Date:
2025-12-24 @ 4:14 PM
NCT ID:
NCT02559466
Eligibility Criteria:
Inclusion Criteria:
* Patients who met the diagnosis of major depressive episode (MDE)
* Patient right-handed
* Men and women aged over 18 years with major depressive episode IV (DSM-IV criteria), isolated or recurrent.
* Scores on the scale MADRS\> 20
* Resistance Criterion defined as the failure of two antidepressants effective dose for a minimum of six weeks.
* Drug Therapy stable for at least 2 weeks
Exclusion Criteria:
* Bipolar disorder type I or type II
* Depression With Psychotic Features
* Diagnosis according comorbid Axis I (DSM IV) with schizophrenia, alcohol abuse and / or toxic substances.
* Inpatient under stress or under legal protection measure (guardianship, curatorship)
* Counter to the practice of Transcranial Magnetic Stimulation : a personal history of seizure, history of neurological or neurosurgical pathologies, metallic prosthetic material or foreign objects (pacemakers, prosthetic eye equipment, etc.).
* Pregnant or breastfeeding ongoing.
* Somatic disorder may affect cognitive abilities and brain structures
* Known allergy to any component of Fludeoxyglucose
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02559466
Study Brief:
Protocol Section:
NCT02559466